Follow the 拱东医疗 stock price and the full directors' dealings record of the company, a listed issuer based in China. Shares are quoted on CN CN, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 拱东医疗 has recorded 11 insider filings. Market capitalisation: €4.1bn. The latest transaction was reported on 1 April 2025 (Sale). Among the most active insiders: 钟卫峰. The full history is free.
11
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
11 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 16,653 of 26,212 companies
43.3
score / 100
Value
38
Quality
49
FCF yld3.5%
Earn yld1.3%
EV/EBITDA25.2x
ROE3.2%
Gross mgn28%
Net mgn4.5%
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.